Delaware | 000-06920 | 94-1655526 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3050 Bowers Avenue | ||
P.O. Box 58039 | ||
Santa Clara, CA | 95052-8039 | |
(Address of principal executive | (Zip Code) | |
offices) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition | ||||||||
Item 9.01 Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EX-99.1 |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated August 11, 2009. |
Applied Materials, Inc. (Registrant) |
||||
Date: August 11, 2009 | By: | /s/ Joseph J. Sweeney | ||
Joseph J. Sweeney | ||||
Senior Vice President, General Counsel and Corporate Secretary |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated August 11, 2009. |
CONTACT: | ||
Howard Clabo (editorial/media) 408.748.5775 | ||
NEWS RELEASE | Michael Sullivan (financial community) 408.986.7977 |
Q3 FY 09 | Q2 FY 09 | Q3 FY 08 | ||||||||||
Net sales |
$1.13 billion | $1.02 billion | $1.85 billion | |||||||||
Net income (loss) |
($55 million) | ($255 million) | $165 million | |||||||||
Earnings (loss) per share |
($0.04 | ) | ($0.19 | ) | $ | 0.12 |
Q3 FY 09 | Q2 FY 09 | Q3 FY 08 | ||||||||||
Non-GAAP net income (loss) |
($2 million) | ($136 million) | $228 million | |||||||||
Non-GAAP earnings (loss) per share |
($0.00 | ) | ($0.10 | ) | $ | 0.17 |
Q3 FY 09 | Q2 FY 09 | Q3 FY 08 | ||||||||||||||||||||||||||||||||||
Operating | Operating | Operating | ||||||||||||||||||||||||||||||||||
New | Net | Income | New | Net | Income | New | Net | Income | ||||||||||||||||||||||||||||
(In millions) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | |||||||||||||||||||||||||||
SSG |
$ | 542 | $ | 498 | $ | 56 | $ | 259 | $ | 260 | $ | (96 | ) | $ | 793 | $ | 756 | $ | 172 | |||||||||||||||||
Applied Global Services |
$ | 298 | $ | 343 | $ | 24 | $ | 236 | $ | 319 | $ | (1 | ) | $ | 541 | $ | 607 | $ | 145 | |||||||||||||||||
Display |
$ | 96 | $ | 69 | $ | (5 | ) | $ | 13 | $ | 84 | $ | 1 | $ | 374 | $ | 311 | $ | 103 | |||||||||||||||||
Energy
and Environmental Solutions |
$ | 136 | $ | 224 | $ | (53 | ) | $ | 141 | $ | 357 | $ | (93 | ) | $ | 322 | $ | 174 | $ | (85 | ) |
Three Months Ended | Nine Months Ended | |||||||||||||||
July 26, | July 27, | July 26, | July 27, | |||||||||||||
(In thousands, except per share amounts) | 2009 | 2008 | 2009 | 2008 | ||||||||||||
Net sales |
$ | 1,133,740 | $ | 1,848,168 | $ | 3,487,213 | $ | 6,085,563 | ||||||||
Cost of products sold |
808,866 | 1,105,854 | 2,615,244 | 3,441,440 | ||||||||||||
Gross margin |
324,874 | 742,314 | 871,969 | 2,644,123 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research, development and engineering |
234,052 | 268,559 | 699,927 | 828,900 | ||||||||||||
General and administrative |
88,487 | 129,341 | 330,808 | 367,352 | ||||||||||||
Marketing and selling |
79,518 | 115,944 | 248,311 | 359,271 | ||||||||||||
Restructuring and asset impairments |
| 138 | 159,481 | 49,634 | ||||||||||||
Income (loss) from operations |
(77,183 | ) | 228,332 | (566,558 | ) | 1,038,966 | ||||||||||
Pre-tax loss of equity method investment |
| 6,308 | 34,983 | 25,660 | ||||||||||||
Impairment of equity method investment
and strategic investments |
2,341 | | 79,422 | | ||||||||||||
Interest expense |
4,893 | 4,859 | 15,945 | 15,660 | ||||||||||||
Interest income |
10,233 | 25,399 | 37,257 | 88,383 | ||||||||||||
Income (loss) before income taxes |
(74,184 | ) | 242,564 | (659,651 | ) | 1,086,029 | ||||||||||
Provision (benefit) for income taxes |
(19,319 | ) | 77,796 | (216,462 | ) | 356,378 | ||||||||||
Net income (loss) |
$ | (54,865 | ) | $ | 164,768 | $ | (443,189 | ) | $ | 729,651 | ||||||
Earnings (loss) per share: |
||||||||||||||||
Basic |
$ | (0.04 | ) | $ | 0.12 | $ | (0.33 | ) | $ | 0.54 | ||||||
Diluted |
$ | (0.04 | ) | $ | 0.12 | $ | (0.33 | ) | $ | 0.53 | ||||||
Weighted average number of shares: |
||||||||||||||||
Basic |
1,333,278 | 1,350,526 | 1,331,410 | 1,359,492 | ||||||||||||
Diluted |
1,333,278 | 1,367,557 | 1,331,410 | 1,375,656 |
July 26, | October 26, | |||||||
(In thousands) | 2009 | 2008 | ||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 1,555,470 | $ | 1,411,624 | ||||
Short-term investments |
583,188 | 689,044 | ||||||
Accounts receivable, net |
842,169 | 1,691,027 | ||||||
Inventories |
1,748,507 | 1,987,017 | ||||||
Deferred income taxes, net |
304,706 | 388,807 | ||||||
Income taxes receivable |
421,935 | 125,605 | ||||||
Other current assets |
308,817 | 371,033 | ||||||
Total current assets |
5,764,792 | 6,664,157 | ||||||
Long-term investments |
990,167 | 1,367,056 | ||||||
Property, plant and equipment |
2,876,731 | 2,831,952 | ||||||
Less: accumulated depreciation and amortization |
(1,788,673 | ) | (1,737,752 | ) | ||||
Net property, plant and equipment |
1,088,058 | 1,094,200 | ||||||
Goodwill, net |
1,171,740 | 1,174,673 | ||||||
Purchased technology and other intangible assets, net |
327,351 | 388,429 | ||||||
Equity method investment |
| 79,533 | ||||||
Deferred income taxes and other assets |
238,173 | 238,270 | ||||||
Total assets |
$ | 9,580,281 | $ | 11,006,318 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of long-term debt |
$ | 1,203 | $ | 1,068 | ||||
Accounts payable and accrued expenses |
1,056,532 | 1,545,355 | ||||||
Customer deposits and deferred revenue |
911,485 | 1,225,735 | ||||||
Income taxes payable |
69,763 | 173,394 | ||||||
Total current liabilities |
2,038,983 | 2,945,552 | ||||||
Long-term debt |
201,200 | 201,576 | ||||||
Other liabilities |
326,489 | 310,232 | ||||||
Total liabilities |
2,566,672 | 3,457,360 | ||||||
Stockholders equity: |
||||||||
Common stock |
13,337 | 13,308 | ||||||
Additional paid-in capital |
5,198,613 | 5,095,894 | ||||||
Retained earnings |
10,896,826 | 11,601,288 | ||||||
Treasury stock |
(9,100,915 | ) | (9,134,962 | ) | ||||
Accumulated other comprehensive income (loss) |
5,748 | (26,570 | ) | |||||
Total stockholders equity |
7,013,609 | 7,548,958 | ||||||
Total liabilities and stockholders equity |
$ | 9,580,281 | $ | 11,006,318 | ||||
Nine Months Ended | ||||||||
July 26, | July 27, | |||||||
(In thousands) | 2009 | 2008 | ||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | (443,189 | ) | $ | 729,651 | |||
Adjustments required to reconcile net income (loss) to cash provided
by (used in) operating activities: |
||||||||
Depreciation and amortization |
219,609 | 240,039 | ||||||
Loss on fixed asset retirements |
16,165 | 27,880 | ||||||
Provision for bad debts |
62,539 | | ||||||
Restructuring and asset impairments |
159,481 | 49,634 | ||||||
Deferred income taxes |
96,117 | (60,886 | ) | |||||
Excess tax benefits from equity-based compensation plans |
| (5,406 | ) | |||||
Net recognized loss (gain) on investments |
13,083 | (1,244 | ) | |||||
Pretax loss of equity-method investment |
34,983 | 25,660 | ||||||
Impairment of equity-method investment and strategic investments |
79,422 | | ||||||
Equity-based compensation |
116,114 | 135,165 | ||||||
Changes in operating assets and liabilities, net of amounts acquired: |
||||||||
Accounts receivable |
786,319 | 534,104 | ||||||
Inventories |
238,510 | (504,555 | ) | |||||
Other current assets |
49,990 | 77,593 | ||||||
Other assets |
(7,134 | ) | (4,383 | ) | ||||
Accounts payable and accrued expenses |
(632,193 | ) | 530,347 | |||||
Customer deposits and deferred revenue |
(314,250 | ) | (127,423 | ) | ||||
Income taxes |
(419,297 | ) | (66,603 | ) | ||||
Other liabilities |
36,527 | 4,578 | ||||||
Cash provided by operating activities |
92,796 | 1,584,151 | ||||||
Cash flows from investing activities: |
||||||||
Capital expenditures |
(187,804 | ) | (209,512 | ) | ||||
Cash paid for acquisition, net of cash acquired |
| (235,324 | ) | |||||
Proceeds from sales and maturities of investments |
1,121,026 | 4,514,648 | ||||||
Purchases of investments |
(649,417 | ) | (4,608,845 | ) | ||||
Cash provided by (used in) investing activities |
283,805 | (539,033 | ) | |||||
Cash flows from financing activities: |
||||||||
Debt repayments |
(241 | ) | (1,854 | ) | ||||
Proceeds from common stock issuances |
29,406 | 334,575 | ||||||
Common stock repurchases |
(22,906 | ) | (1,199,984 | ) | ||||
Excess tax benefits from equity-based compensation plans |
| 5,406 | ||||||
Payment of dividends to stockholders |
(239,756 | ) | (245,559 | ) | ||||
Cash used in financing activities |
(233,497 | ) | (1,107,416 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents |
742 | 108 | ||||||
Increase (decrease) in cash and cash equivalents |
143,846 | (62,190 | ) | |||||
Cash and cash equivalents beginning of period |
1,411,624 | 1,202,722 | ||||||
Cash and cash equivalents end of period |
$ | 1,555,470 | $ | 1,140,532 | ||||
Supplemental cash flow information: |
||||||||
Cash payments for income taxes |
$ | 139,625 | $ | 349,914 | ||||
Cash payments for interest |
$ | 7,212 | $ | 7,243 |
Three Months Ended | Nine Months Ended | |||||||||||||||||||
July 26, | April 26, | July 27, | July 26, | July 27, | ||||||||||||||||
(In thousands, except per share amounts) | 2009 | 2009 | 2008 | 2009 | 2008 | |||||||||||||||
Non-GAAP Net Income (Loss) |
||||||||||||||||||||
Reported net income (loss) (GAAP basis) |
$ | (54,865 | ) | $ | (255,390 | ) | $ | 164,768 | $ | (443,189 | ) | $ | 729,651 | |||||||
Equity-based compensation expense |
43,334 | 39,172 | 46,121 | 116,114 | 135,165 | |||||||||||||||
Certain items associated with acquisitions 1 |
22,425 | 24,824 | 41,109 | 73,274 | 103,291 | |||||||||||||||
Restructuring and asset impairments 2,3,4 |
| 26,709 | 138 | 159,481 | 49,634 | |||||||||||||||
Costs associated with ceasing development
of beamline implant products 5 |
| | 156 | | 1,436 | |||||||||||||||
Impairment of equity method investment and
strategic investments |
2,341 | 77,081 | | 79,422 | | |||||||||||||||
Income tax effect of non-GAAP adjustments
and resolution of audits of prior years
income tax filings |
(14,791 | ) | (48,040 | ) | (24,601 | ) | (125,770 | ) | (85,069 | ) | ||||||||||
Non-GAAP net income (loss) |
$ | (1,556 | ) | $ | (135,644 | ) | $ | 227,691 | $ | (140,668 | ) | $ | 934,108 | |||||||
Non-GAAP Net Income (Loss) Per Diluted Share |
||||||||||||||||||||
Reported net income (loss) per diluted share
(GAAP basis) |
$ | (0.04 | ) | $ | (0.19 | ) | $ | 0.12 | $ | (0.33 | ) | $ | 0.53 | |||||||
Equity-based compensation expense |
0.02 | 0.02 | 0.02 | 0.06 | 0.07 | |||||||||||||||
Certain items associated with acquisitions |
0.01 | 0.01 | 0.02 | 0.04 | 0.05 | |||||||||||||||
Restructuring and asset impairments |
| 0.01 | | 0.08 | 0.02 | |||||||||||||||
Costs associated with ceasing development
of beamline implant products |
| | | | | |||||||||||||||
Impairment of equity method investment and
strategic investments |
| 0.05 | | 0.05 | | |||||||||||||||
Resolution of audits of prior years income tax filings |
| (0.01 | ) | | | | ||||||||||||||
Non-GAAP net income (loss) per diluted share |
$ | (0.00 | ) | $ | (0.10 | ) | $ | 0.17 | $ | (0.11 | ) | $ | 0.68 | |||||||
Shares used in diluted shares calculation |
1,333,278 | 1,331,729 | 1,367,557 | 1,331,410 | 1,375,656 |
1 | These items are incremental charges attributable to acquisitions consisting of inventory fair value adjustments on products sold and amortization of purchased intangible assets. | |
2 | Results for the three months ended April 26, 2009 included asset impairment charges of $15 million related to wafer cleaning equipment and restructuring charges of $12 million primarily associated with a restructuring program announced on November 12, 2008. Results for the nine months ended July 26, 2009 included asset impairment charges of $15 million related to wafer cleaning equipment and restructuring charges of $145 million associated with a restructuring program announced on November 12, 2008. | |
3 | Results for the nine months ended July 27, 2008 included restructuring charges of $38 million associated with a global cost reduction plan. | |
4 | Results for the three and nine months ended July 27, 2008 included restructuring and asset impairment charges of $138,000 and $12 million, respectively, associated with ceasing development of beamline implant products. | |
5 | Results for the three and nine months ended July 27, 2008 included other operating charges of $156,000 and $1 million, respectively, associated with ceasing development of beamline implant products. |